Cargando…
ALLY in fighting COVID-19: magnitude of albumin decline and lymphopenia (ALLY) predict progression to critical disease
The global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic leading to coronavirus disease 2019 (COVID-19) is straining hospitals. Judicious resource allocation is paramount but difficult due to the unpredictable disease course. Once hospitalized, discerning which patients may p...
Autores principales: | van Zyl, Johanna S, Alam, Amit, Felius, Joost, Youssef, Ronnie M, Bhakta, Dipesh, Jack, Christina, Jamil, Aayla K, Hall, Shelley A, Klintmalm, Göran B, Spak, Cedric W, Gottlieb, Robert L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802390/ https://www.ncbi.nlm.nih.gov/pubmed/33431604 http://dx.doi.org/10.1136/jim-2020-001525 |
Ejemplares similares
-
Pneumothorax and Pneumomediastinum in COVID-19 Suggest a Pneumocystic Pathology
por: Jamil, Aayla K., et al.
Publicado: (2021) -
Nelfinavir: An Old Ally in the COVID-19 Fight?
por: Gidari, Anna, et al.
Publicado: (2022) -
Discovery science, an ally in the fight against antimicrobial resistance
Publicado: (2022) -
Understanding HAIs: Ally proteins in the fight against cancer
por: Nonboe, Annika W., et al.
Publicado: (2022) -
Radiotherapy imaging: An unexpected ally in fighting COVID 19 pandemic()
por: Boldrini, Luca, et al.
Publicado: (2020)